Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REtrospective, obserVational Study to Describe the Treatment Patterns and Outcomes of Epidermal Growth Factor Receptor Mutant (EGFRm) Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) Patients in Belgium

NCT03761901 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03761901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03761901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REtrospective, obserVational Study to Describe the Treatment Patterns and Outcomes of Epidermal Growth Factor Receptor Mutant (EGFRm) Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) Patients in Belgium
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 21, 2018
Completion date
June 19, 2019
Enrollment
141 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung